Testosterone esters compared
Sustanon 250 vs testosterone cypionate
A blend of testosterone esters and a single ester, each figure tied to its own label or study.
Sustanon 250 is a blend of testosterone propionate, phenylpropionate, isocaproate and decanoate in one 1 mL ampoule of arachis oil, and testosterone cypionate is a single ester of testosterone.1,2 The UK Sustanon label states that one injection of 1 mL per 3 weeks is usually adequate, and the Azmiro cypionate label gives 50 to 400 mg every two to four weeks.1,3
The Depo-Testosterone label gives the half-life of cypionate as approximately eight days, and the UK Sustanon label states that plasma testosterone returns to the lower limit of the normal range in approximately 21 days.2,1
| Fact | Sustanon 250 | Testosterone Cypionate |
|---|---|---|
| What it is | A blend of testosterone propionate, phenylpropionate, isocaproate and decanoate in a single oil solution1 | The oil-soluble cyclopentylpropionate ester of testosterone2 |
| How it comes | A 1 mL ampoule in arachis oil: 30 mg propionate, 60 mg phenylpropionate, 60 mg isocaproate and 100 mg decanoate, 250 mg of esters and 176 mg of testosterone1,6 | Oil for deep intramuscular injection: Depo-Testosterone at 100 or 200 mg/mL, Azmiro at 200 mg/mL2,3 |
| Half-life | ||
| Studied doses | ||
| Status | UK label: testosterone replacement therapy for male hypogonadism, and supportive therapy for female-to-male transsexuals1. WADA prohibits anabolic agents (S1) at all times10 | Labelled for testosterone replacement therapy; a Schedule III controlled substance in the US2. WADA prohibits anabolic agents (S1) at all times10 |
Last reviewed . Sources are listed below.
How they differ
Sustanon 250 is in refined arachis oil with benzyl alcohol, and Depo-Testosterone is in cottonseed oil with benzyl benzoate and benzyl alcohol as the preservative.1,2 The UK label gives the total amount of testosterone in each mL of Sustanon 250 as 176 mg.1
The Azmiro label states that injectable testosterone products may have different doses, strengths or administration instructions and are not substitutable on a milligram-per-milligram basis.3
Logged in Milligram
- Sustanon 250: Too few people logged it to show a share.
- Testosterone Cypionate: 13% of people who logged a dose in Milligram logged it in the 90 days to 15 November 2026.
Shares of people who logged a dose in Milligram in the 90 days to 15 November 2026, shown only where at least 50 people logged three or more doses of the compound.
What is not known
The decanoate figure of approximately 10 days comes from a 2027 trial paper, not from the Sustanon label.4 A 2019 trial gives a half-life of 4 to 5 days for testosterone itself, not for any one ester.5
The Azmiro label states that the exposure-response relationship and time course of pharmacodynamic response for testosterone have not been fully characterized.3
References
- Aspen Pharma Trading Limited. Sustanon 250, 250mg/ml solution for injection - Summary of Product Characteristics. Label (UK SmPC), electronic Medicines Compendium (UK), revised December 2025. medicines.org.uk
- Pharmacia & Upjohn Company LLC (Pfizer). Depo-Testosterone (testosterone cypionate) injection, USP CIII (Pharmacia & Upjohn Company LLC). US prescribing information, 2025. DailyMed label
- Azurity Pharmaceuticals, Inc. AZMIRO (testosterone cypionate) injection, for intramuscular use, CIII (Azurity Pharmaceuticals, Inc.). US prescribing information, 2025. DailyMed label
- Main AM, Solheim SA, Wagner SP, Albrechtsen HM, Nordsborg NB, Winge SB, Juul A, Morup N, Almstrup K. Temporal Effects of Exogenous Testosterone on the Circulating Small Noncoding RNA Landscape in a Placebo-Controlled Human Study. Randomized trial (secondary analysis), Andrology 2027. PMC13748923
- Gharahdaghi N, Rudrappa S, Brook MS, Idris I, Crossland H, Hamrock C, Abdul Aziz MH, Kadi F, Tarum J, Greenhaff PL, Constantin-Teodosiu D, Cegielski J, Phillips BE, Wilkinson DJ, Szewczyk NJ, Smith K, Atherton PJ. Testosterone therapy induces molecular programming augmenting physiological adaptations to resistance exercise in older men. Randomized trial, J Cachexia Sarcopenia Muscle 2019. PMC6903447
- Pharmacy Retailing (NZ) Ltd. Sustanon data sheet (New Zealand data sheet). Label (NZ data sheet), Medsafe (New Zealand), revised 14 January 2026. medsafe.govt.nz
- Turza A, Popescu V, Mare L, Borodi G. Structural Aspects and Intermolecular Energy for Some Short Testosterone Esters. Research article, Materials (Basel) 2022. PMC9611952
- Bi Y, Perry PJ, Ellerby M, Murry DJ. Population Pharmacokinetic/Pharmacodynamic Modeling of Depot Testosterone Cypionate in Healthy Male Subjects. randomized trial, population model, 2018. PMC5915615
- Anderson FH, Francis RM, Faulkner K. Androgen supplementation in eugonadal men with osteoporosis-effects of 6 months of treatment on bone mineral density and cardiovascular risk factors. PubMed record, Bone 1996. PMID 8833211
- World Anti-Doping Agency. World Anti-Doping Code International Standard: Prohibited List 2026. Prohibited List, 2026. wada-ama.org